| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/06/2005 | WO2005000874A1 Biologically active peptide comprising tyrosyl-seryl-valine (ysv) |
| 01/06/2005 | WO2005000872A2 Collagen mimics |
| 01/06/2005 | WO2005000285A2 METHODS OF TREATING NON-INFLAMMATORY GASTROINTESTINAL TRACT DISORDERS USING Cav2.2 SUBUNIT CALCIUM CHANNEL MODULATORS |
| 01/06/2005 | WO2004101494B1 Calpain inhibitors |
| 01/06/2005 | WO2004089396A3 Anti-fungal peptidomimetics |
| 01/06/2005 | US20050004230 Retroviral protease inhibitors |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004100 Cardiovascular disorders; kidney disorders; antiinflammatory agents |
| 01/06/2005 | US20050004043 Protease inhibitors; human t-cell leukemia virus; aids |
| 01/06/2005 | US20050004042 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 01/06/2005 | US20050004041 Obtained by hydrolysis of casein; hypotensive agents; foods, drugs |
| 01/06/2005 | US20050004038 Therapy for drug resistant cancer, malaria,hematopoiesis |
| 01/06/2005 | US20050004032 COMPRISING TRIPEPTIDE UNIT OF THE FORMULA (flp-Yaa-Gly)N, WHERE Yaa IS ANY AMINO ACID, FLP IS 4(R)-FLUORO-L-PROLINE, AND N IS AT LEAST 3; INCREASED STABILITY; STRONGER TRIPLE HELIX THAN NATIVE COLLAGEN; FOR USE SUCH AS IN ARTIFICIAL SKIN |
| 01/06/2005 | US20050004016 Quantitative analysis of amino acid sequences; genetic engineering |
| 01/06/2005 | US20050004009 Peptidomimetic inhibitors of STAT activity and uses thereof |
| 01/06/2005 | US20050003448 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 01/06/2005 | US20050003387 Using tumor necrosis factor-related apoptosis-inducing ligand as a tool to identify modulators of programmed cell death for use in treatment of cell proliferative disorders |
| 01/06/2005 | US20050003345 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/06/2005 | CA2529371A1 Cytotoxic depsipeptides |
| 01/06/2005 | CA2528353A1 Compositions and methods for treatment of rosacea |
| 01/05/2005 | EP1493825A2 Method for producing nucleic acid ligands |
| 01/05/2005 | EP1493749A1 Novel HCV core + 1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents |
| 01/05/2005 | EP1326523A4 Imaging of enzymatic activity |
| 01/05/2005 | CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 01/05/2005 | CN1183156C Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 01/05/2005 | CN1183155C Peptide useful as ligand |
| 01/04/2005 | US6838547 Acryloyl derivatives of distamycin conjugated with glutathione; have antitumor activity and are thus useful in therapy in the treatment of cancer |
| 01/04/2005 | US6838478 Use as anticoagulants; competitive inhibitors of thrombin; for example, 1-(phenyl-2-hydroxyethane-1,1-diylcarbonyl), 2-((4-amidinophenyl)-alkylaminocarbonyl)azetidine |
| 01/04/2005 | US6838475 For prophylaxis and therapy of one or more symptoms of hepatitis C |
| 01/04/2005 | US6838455 Inhibiting beta -amyloid peptide release and/or its synthesis in a cell by administering deoxyamino acid compound |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/04/2005 | US6838261 Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteins |
| 01/04/2005 | US6838259 Process for producing kiss-1 peptide |
| 01/04/2005 | CA2187502C Sweetener salts |
| 01/04/2005 | CA2144331C Process for the selective increase of production of antibiotic ge 2270 factor a |
| 01/04/2005 | CA2109482C Process for producing alanylglutamine |
| 12/30/2004 | US20040268423 inhibiting formation of neurofibrillary tangles by reducing formation of a carboxyl-terminal truncated form of apolipoprotein E (apoE) in a neuron in the individual; animal models of Alzheimer's disease (AD); treating AD; drug screening |
| 12/30/2004 | US20040266991 Biologically active peptides and their use for repairing injured nerves |
| 12/30/2004 | US20040266766 Selective urokinase inhibitors |
| 12/30/2004 | US20040266731 Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease |
| 12/30/2004 | US20040266698 Pyrane derivatives as both ace-and nep-inhibitors |
| 12/30/2004 | US20040266696 activating neovascularization by administering heptapeptides having replacements in the amino acid sequence; antiischemic agents; regeneration and maintenance of artificial bones |
| 12/30/2004 | US20040266687 Antiproliferative agents; antiinflammatory agents; angiogenesis inhibitors; anticancer agents |
| 12/30/2004 | US20040266668 Prevent reproduction of hepatitis virus |
| 12/30/2004 | US20040266664 Enzyme inhibition |
| 12/30/2004 | US20040265976 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography |
| 12/30/2004 | US20040265974 Human chemokine polypeptides |
| 12/30/2004 | US20040265911 Peptides for use in culture media |
| 12/30/2004 | US20040265910 peptides which include cell-growth affecting peptides and peptides which enhance or inhibit production of cellular proteins formulated in culture medium to produce the desired effect on cultured cells; useful in concatemer-based recombinant expression methods |
| 12/29/2004 | WO2004113530A1 Polynucleotide for synthesis of labeled protein |
| 12/29/2004 | WO2004113366A1 Histone deacetylase inhibitor and process for producing the same |
| 12/29/2004 | WO2004113365A2 Hepatitis c serine protease tri-peptide inhibitors |
| 12/29/2004 | WO2004113364A1 New process for the production of melagatran |
| 12/29/2004 | WO2004113363A2 Dipeptide transglutaminase inhibitors and methods of using the same |
| 12/29/2004 | WO2004113294A1 Process and intermediates for the preparation of (1r, 2s, 5s)-3-azabicyclo[3, 1, 0]hexane-2-carboxamide, n-[3-amino-1-(cyclobutylmethyl)-2, 3-dioxopropyl] ]-3-[(2s)-2-[[[1, 1-dimethylethyl]amino]carbonylamino]-3, 3-dimethyl-1-oxobutyl]-6, 6-dimethyl |
| 12/29/2004 | WO2004112572A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/29/2004 | EP1491552A2 Method and apparatus for the microwave-assisted peptide synthesis |
| 12/29/2004 | EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 12/29/2004 | EP1343516A4 Analogues of thiocoraline and be-22179 |
| 12/29/2004 | CN1558947A Peptide synthase gene, peptide synthase and process for producing dipdptide |
| 12/29/2004 | CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer |
| 12/29/2004 | CN1557834A Process for producing cyclo (D-phenylpropyl-D-group) dipeptide |
| 12/29/2004 | CN1182154C Novel dolastatin derivatives, their preparation and use |
| 12/29/2004 | CN1182153C Novel dolastatin derivatives, their preparation and use |
| 12/29/2004 | CA2529045A1 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/29/2004 | CA2528930A1 New process for the production of melagatran |
| 12/28/2004 | US6835843 Amidation, deprotected by catalytic hydrogenation, salt formation with tributylamine |
| 12/28/2004 | US6835811 Extended storage of reduced glutathione solutions |
| 12/28/2004 | US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt |
| 12/28/2004 | US6835714 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 12/28/2004 | US6835712 Compounds |
| 12/28/2004 | US6835382 Ii peptide therapeutics to enhance antigen presentation |
| 12/23/2004 | WO2004111192A2 Targeted delivery to legumain-expressing cells |
| 12/23/2004 | WO2004111077A1 Macrocyclic antagonists of the motilin receptor |
| 12/23/2004 | WO2004111076A1 Triamide derivative and process for producing the same |
| 12/23/2004 | WO2004110432A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases |
| 12/23/2004 | WO2004110390A2 Anti-cd74 immunoconjugates and methods |
| 12/23/2004 | US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis |
| 12/23/2004 | US20040260059 [microwave-assisted peptide synthesis] |
| 12/23/2004 | US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 12/23/2004 | US20040259807 Monocyte locomotion inhibitory factor |
| 12/23/2004 | US20040259805 Stimulant of milk ejection; contraction; stability |
| 12/23/2004 | US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 12/23/2004 | US20040259798 Drugs; integrin antagonist; antiinflammatory agents; leukemia therapy |
| 12/23/2004 | US20040258821 purification of aspartame or neotame slurries using water and compressed air, which forces impurities through filters, then recovering and dehydrating the crystals |
| 12/23/2004 | DE10323898A1 Hydroxyamidin- und Hydroxyguanidin-Verbindungen als Urokinase-Hemmstoffe Hydroxyamidine and hydroxyguanidine compounds as inhibitors of urokinase |
| 12/23/2004 | CA2765196A1 Microwave-assisted peptide synthesis |
| 12/23/2004 | CA2536357A1 Targeted delivery to legumain-expressing cells |
| 12/23/2004 | CA2529496A1 Anti-cd74 immunoconjugates and methods |
| 12/23/2004 | CA2529478A1 Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases |
| 12/23/2004 | CA2528375A1 Macrocyclic antagonists of the motilin receptor |
| 12/22/2004 | EP1489125A1 Compound of hydrophilic polymer-polycarboxyl oligopeptide and medicines, medical composite comprising above compound and use of above compound in medicimes |
| 12/22/2004 | EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
| 12/22/2004 | EP1487997A2 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents |
| 12/22/2004 | EP1487826A1 New crystalline forms of (2s)-n-5- amino(imino)methyl -thienylmethyl-1-(2r)-2- (carboxymethyl)amino -3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o |
| 12/22/2004 | EP1487788A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds |
| 12/22/2004 | EP1487459A1 Peptide analogues and uses thereof |
| 12/22/2004 | EP1363656B1 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 12/22/2004 | EP1226230B1 Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| 12/22/2004 | CN1556701A Tetrapeptide derivative crystals |